NO20000151L - Nitrogenoksid inhiberer rhinovirus infeksjon - Google Patents

Nitrogenoksid inhiberer rhinovirus infeksjon

Info

Publication number
NO20000151L
NO20000151L NO20000151A NO20000151A NO20000151L NO 20000151 L NO20000151 L NO 20000151L NO 20000151 A NO20000151 A NO 20000151A NO 20000151 A NO20000151 A NO 20000151A NO 20000151 L NO20000151 L NO 20000151L
Authority
NO
Norway
Prior art keywords
nitric oxide
rhinovirus infection
oxide inhibits
inhibits rhinovirus
inhibit
Prior art date
Application number
NO20000151A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000151D0 (no
Inventor
Scherer P Sanders
David Proud
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of NO20000151D0 publication Critical patent/NO20000151D0/no
Publication of NO20000151L publication Critical patent/NO20000151L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20000151A 1997-07-11 2000-01-11 Nitrogenoksid inhiberer rhinovirus infeksjon NO20000151L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5230797P 1997-07-11 1997-07-11
PCT/US1998/014466 WO1999002148A1 (en) 1997-07-11 1998-07-10 Nitric oxide inhibits rhinovirus infection

Publications (2)

Publication Number Publication Date
NO20000151D0 NO20000151D0 (no) 2000-01-11
NO20000151L true NO20000151L (no) 2000-03-09

Family

ID=21976738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000151A NO20000151L (no) 1997-07-11 2000-01-11 Nitrogenoksid inhiberer rhinovirus infeksjon

Country Status (14)

Country Link
US (1) US6277891B1 (id)
EP (1) EP1011657A1 (id)
JP (1) JP2001509481A (id)
KR (1) KR20010021749A (id)
CN (1) CN1277552A (id)
AU (1) AU8399098A (id)
BR (1) BR9811473A (id)
CA (1) CA2303430A1 (id)
CZ (1) CZ200092A3 (id)
HU (1) HUP0002859A2 (id)
ID (1) ID23780A (id)
NO (1) NO20000151L (id)
TR (1) TR200000157T2 (id)
WO (1) WO1999002148A1 (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030753A1 (es) * 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
DE10303196A1 (de) * 2003-01-28 2004-08-12 Märtz, Hans Helmut Verwendung von Erzeugnissen, Stoffen oder Stoffgemischen, aus welchen im menschlichen oder tierischen Körper Stickoxid (Formel: NO) entsteht, zur Behandlung oder Prophylaxe von Infektionskrankheiten des menschlichen oder tierischen Körpers
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
JP5564157B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 心臓血管状態の処置のための亜硝酸塩の使用方法
US8252591B2 (en) * 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006125123A2 (en) 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
EP2188367A4 (en) 2007-08-10 2010-10-27 Whitehead Biomedical Inst HORMON'S TREATIVE TISSUE CULTURE SYSTEM AND USES THEREOF
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
JP5558458B2 (ja) * 2008-03-20 2014-07-23 タノメド・アクチボラゲット 普通感冒の治療用の医薬の製造における物質の使用
EP3645010A4 (en) * 2017-06-27 2021-03-24 Ohio State Innovation Foundation NUCLEOTIDE-BASED THERAPY FOR ASTHMA
CN109432122A (zh) * 2018-11-19 2019-03-08 罗辉 No或no供体在制备预防和/或治疗皮肤疾病或黏膜疾病药物中的应用及药物组合物
CN109846113A (zh) * 2018-11-29 2019-06-07 南京诺全生物医疗科技有限公司 一种可自提供一氧化氮的口鼻卫生用品
WO2021158954A1 (en) * 2020-02-07 2021-08-12 Know Bio, Llc Nitric oxide-releasing antibacterial compounds, formulations, and methods pertaining thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455279A (en) 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine

Also Published As

Publication number Publication date
CZ200092A3 (en) 2001-05-16
JP2001509481A (ja) 2001-07-24
EP1011657A1 (en) 2000-06-28
AU8399098A (en) 1999-02-08
ID23780A (id) 2000-05-11
HUP0002859A2 (hu) 2001-01-29
TR200000157T2 (tr) 2001-06-21
KR20010021749A (ko) 2001-03-15
BR9811473A (pt) 2001-12-26
NO20000151D0 (no) 2000-01-11
WO1999002148A1 (en) 1999-01-21
US6277891B1 (en) 2001-08-21
CN1277552A (zh) 2000-12-20
CA2303430A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
DK66493D0 (da) Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
EA200300810A1 (ru) Вирус, вызывающий заболевание дыхательных путей у восприимчивых млекопитающих
AP1771A (en) 3&#39;-Prodrugs of 2&#39;-deoxy-?-L-nucleosides.
ATE329622T1 (de) Steigerung der antikörper-zytokin- fusionsproteinmediierten immunantwort durch mitverabreichung mit einem angiogeneseinhibitor
Awasthi et al. OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath
EP1340744A3 (en) Hiv protease inhibitors
DK0933993T3 (da) Substituerede cyclopentanforbindelser, der er egnede som neuraminidaseinhibitorer
DE69430232D1 (de) Hemmung der Symptome des prämenstruellen Synchroms/dysphorische Erkrankungen der späten lutealen Phase
MEP35308A (en) COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF
BR9811473A (pt) Infecção por rinovìrus inibida por óxido nìtrico
CO5200855A1 (es) Uso de csaids en infecciones por rinovirus
ES2123156T3 (es) Compuestos y procedimientos de inhibicion de hiv y virus semejantes.
DK1089744T3 (da) Neurobeskyttende præparat til forebyggelse og/eller behandling af nervøse og adfærdsmæssige ændringer på grund af angsttilstande eller depression omfattende acetyl-L-carnitin og hypericin
ES2058418T3 (es) Preparacion farmaceutica contra enfermedades viricas que comprende un extracto de higado.
DK208987D0 (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
AR125121A1 (es) Actividad antiviral de inhibidores de vps34
WO2002069960A3 (en) Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock
NO20053455L (no) Anvendelse av en kombinasjon inneholdende en ikke-nukleosid revers transkriptase inhibitor (NNRTI) med en inhibitor av cytokrom P450 sa som protease inhibitorer
AP2001002181A0 (en) Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other toga viruses.
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
BR9913598A (pt) Inibidores de protease de hiv
DE3853672D1 (de) Nichtzurückschlagende RNS-Viren.
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
DK0576506T3 (da) Anvendelse af benzimidazol-anthelmintikum ved behandling af mikrosporidial-infektioner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application